Inhibition of GRK2 mitigates cisplatin-induced acute and chronic nephrotoxicity by targeting the NADPH oxidase 4/oxidative stress axis.

Key Points

• This research aims to evaluate the role of GRK2 in cisplatin-induced nephrotoxicity and its potential as a therapeutic target.
• Inhibition of GRK2 in nephrotoxic conditions
• Assessment of kidney function and damage
• Analysis of oxidative stress markers
• GRK2 inhibition significantly reduces acute nephrotoxicity
• Chronic nephrotoxicity is also mitigated
• NOX4 activity correlates with GRK2 modulation